Is XPPLF or MRK a better dividend investment in 2026?

XPPLF currently yields 12.23% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: XPPLF offers higher current income.

What is the dividend yield difference between XPPLF and MRK?

XPPLF has a forward dividend yield of 12.23% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 8.98 percentage points.

Home › Compare › XPPLF vs MRK

XPPLF vs MRK: Dividend Comparison 2026

XPPLF yields 12.23% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRK wins by $8.9K in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

XPPLF

● Live price

12.23%

Share price

$16.35

Annual div

$2.00

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.9K

Annual income

$1.33

Full XPPLF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — XPPLF vs MRK

📍 MRK pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	XPPLF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, XPPLF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

XPPLF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XPPLF

Annual income on $10K today (after 15% tax)

$1,039.76/yr

After 10yr DRIP, annual income (after tax)

$1.13/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, MRK beats the other by $806.62/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XPPLF + MRK for your $10,000?

XPPLF: 50%MRK: 50%

100% MRK50/50100% XPPLF

Portfolio after 10yr

$26.3K

Annual income

$475.81/yr

Blended yield

1.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

XPPLF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

2.4

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XPPLF buys

MRK buys

No recent congressional trades found for XPPLF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricXPPLFMRK

Forward yield	12.23% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	-50%	8.2% ✓
Portfolio after 10y	$21.9K	$30.7K ✓
Annual income after 10y	$1.33	$950.29 ✓
Total dividends collected	$1.3K	$6.1K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: XPPLF vs MRK ($10,000, DRIP)

Year	XPPLF Portfolio	XPPLF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1	$11,312	$611.62	$11,192	$351.54	+$120.00 → XPPLF
2← crossover	$12,427	$323.29	$12,524	$392.70	$97.00 → MRK
3	$13,463	$165.96	$14,015	$438.65	$552.00 → MRK
4	$14,489	$84.02	$15,682	$489.96	$1.2K → MRK
5	$15,545	$42.25	$17,547	$547.23	$2.0K → MRK
6	$16,655	$21.18	$19,632	$611.16	$3.0K → MRK
7	$17,831	$10.61	$21,963	$682.53	$4.1K → MRK
8	$19,085	$5.31	$24,571	$762.18	$5.5K → MRK
9	$20,423	$2.65	$27,486	$851.08	$7.1K → MRK
10	$21,854	$1.33	$30,745	$950.29	$8.9K → MRK

XPPLF vs MRK: Complete Analysis 2026

XPPLF — Stock

XP Power Limited, an investment holding company, designs and manufactures power supply solutions in Europe, North America, and Asia. The company offers AC-DC power supplies, DC-DC converters, high voltage DC-DC converters, high voltage AC-DC power supplies, RF power systems, EMI filters, custom power supplies, and 3 phase power sources. It also offers engineering services. The company serves healthcare, industrial technology, and semiconductor equipment manufacturing industries. XP Power Limited was founded in 1988 and is based in Singapore.

Full XPPLF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this XPPLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XPPLF vs SCHD XPPLF vs JEPI XPPLF vs O XPPLF vs KO XPPLF vs MAIN XPPLF vs JNJ XPPLF vs ABBV XPPLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.